Won Young Tak
Kyungpook National University Hospital(KR)Kyungpook National University(KR)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Hepatocellular Carcinoma Treatment and Prognosis, Hepatitis B Virus Studies, Hepatitis C virus research, Liver Disease and Transplantation
Most-Cited Works
- → Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial(2008)5,801 cited
- → Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial(2015)1,085 cited
- → Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study(2013)766 cited
- → Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial(2016)685 cited
- → Federated learning for predicting clinical outcomes in patients with COVID-19(2021)665 cited
- → Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study(2013)593 cited